Vancouver, British Columbia, Canada The main office of represented VC is situated in the Vancouver. The venture was found in North America in Canada.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Global health sciences venture fund, startups are often financed by Quark Venture, Polaris Partners, NanoDimension. The meaningful sponsors for the fund in investment in the same round are Pontifax, Viva Ventures Biotech Group, Total Access Fund.
The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The fund is constantly included in 2-6 investment rounds annually.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline SQZ Biotech, Canary Medical, ABAC Therapeutics The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Life Science, Medical.
Related Funds
| Fund Name | Location |
| Angelor | France, Lyon, Rhone-Alpes |
| Banco de Investimento Global | Lisboa, Lisbon, Portugal |
| Beyond The Game Network | Atlanta, Georgia, United States |
| Bonanza invest | - |
| Carphone Warehouse | England, London, United Kingdom |
| Elevation Investments | Austria, Vienna |
| Geekhouse Capital | Beijing, Beijing, China |
| InSite | California, Redondo Beach, United States |
| Kitchen Fund | New York, New York, United States |
| Markpoint Venture Partners | Allen, Texas, United States |
| Maroon Venture Partners Fund | Amherst, Massachusetts, United States |
| Mayhem Development | Missouri, Springfield, United States |
| MBM Capital Partners | England, London, United Kingdom |
| Old Kent Road (OKR) Financial | Alberta, Calgary, Canada |
| Otter Rock Capital | California, Los Angeles, United States |
| Palantir Capital | California, Rancho Santa Fe, United States |
| Shenzhen Yidun Media Investment Fund | China, Guangdong, Shenzhen |
| Supcon Group | China, Hangzhou, Zhejiang |
| Venmo | New York, New York, United States |
| Zibo Financial Holding | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Variantyx | $20M | 15 Mar 2021 | Framingham, Massachusetts, United States | ||
ARTMS | $19M | 20 May 2020 | Vancouver, British Columbia, Canada | ||
Keros Therapeutics | $56M | 04 Mar 2020 | Massachusetts, United States | ||
EnClear Therapies | $10M | 19 Feb 2020 | Cambridge, Massachusetts, United States | ||
Volastra Therapeutics | $12M | 11 Feb 2020 | New York, New York, United States | ||
Eyevensys | $30M | 08 Jan 2020 | Ile-de-France | ||
Keros Therapeutics | $23M | 08 Jan 2019 | Massachusetts, United States | ||
SQZ Biotech | $72M | 08 Aug 2018 | Massachusetts, United States | ||
ABAC Therapeutics | $18M | 15 Feb 2018 | Barcelona, Catalonia, Spain |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Variantyx | $20M | 15 Mar 2021 | Framingham, Massachusetts, United States | ||
ARTMS | $19M | 20 May 2020 | Vancouver, British Columbia, Canada | ||
Keros Therapeutics | $56M | 04 Mar 2020 | Massachusetts, United States | ||
EnClear Therapies | $10M | 19 Feb 2020 | Cambridge, Massachusetts, United States | ||
Volastra Therapeutics | $12M | 11 Feb 2020 | New York, New York, United States | ||
Eyevensys | $30M | 08 Jan 2020 | Ile-de-France | ||
Keros Therapeutics | $23M | 08 Jan 2019 | Massachusetts, United States | ||
SQZ Biotech | $72M | 08 Aug 2018 | Massachusetts, United States | ||
ABAC Therapeutics | $18M | 15 Feb 2018 | Barcelona, Catalonia, Spain |
